These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9356598)
1. Nephrosclerosis and hypertension. Ono H; Ono Y Med Clin North Am; 1997 Nov; 81(6):1273-88. PubMed ID: 9356598 [TBL] [Abstract][Full Text] [Related]
2. The glomerular mesangium in hypertension: a morphometrical comparison of nephrosclerosis with mesangioproliferative glomerulonephritis on renal biopsies. Hara M; Meyer D; Bohle A Virchows Arch A Pathol Anat Histol; 1975 Nov; 368(4):275-80. PubMed ID: 813366 [TBL] [Abstract][Full Text] [Related]
3. Renal parenchymal involvement in essential hypertension. Schwartz GL; Strong CG Med Clin North Am; 1987 Sep; 71(5):843-58. PubMed ID: 3306206 [TBL] [Abstract][Full Text] [Related]
4. [Three-dimensional morphologic examination of normal and diseased renal arterioles]. Rázga Z Orv Hetil; 2003 Nov; 144(44):2165-72. PubMed ID: 14686064 [TBL] [Abstract][Full Text] [Related]
5. Nephrosclerosis: update on a centenarian. Meyrier A Nephrol Dial Transplant; 2015 Nov; 30(11):1833-41. PubMed ID: 25488894 [TBL] [Abstract][Full Text] [Related]
6. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Hill GS; Heudes D; Bariéty J Kidney Int; 2003 Mar; 63(3):1027-36. PubMed ID: 12631084 [TBL] [Abstract][Full Text] [Related]
10. Pathology of malignant nephrosclerosis with special reference to the difference between histologic manifestations of pure and exacerbated forms. Fujimoto T Tohoku J Exp Med; 1978 Jun; 125(2):135-53. PubMed ID: 694919 [TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis. Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932 [TBL] [Abstract][Full Text] [Related]
12. Renal vascular lesions in severe hypertension. Transitional changes from benign to malignant nephrosclerosis. Akikusa B; Kondo Y; Irabu N; Shigematsu H Acta Pathol Jpn; 1983 Mar; 33(2):323-31. PubMed ID: 6869004 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of antihypertensive drugs on renal and glomerular hemodynamics and injury in the chronic nitric-oxide-suppressed rat. Zhou X; Frohlich ED Am J Nephrol; 2005; 25(2):138-52. PubMed ID: 15855741 [TBL] [Abstract][Full Text] [Related]
14. Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients. Kimura N; Yonemoto S; Machiguchi T; Li X; Kimura H; Yoshida H Hypertens Res; 2006 Aug; 29(8):573-80. PubMed ID: 17137212 [TBL] [Abstract][Full Text] [Related]
15. Morphometrical and functional correlations in benign nephrosclerosis. Katafuchi R; Takebayashi S Clin Nephrol; 1987 Nov; 28(5):238-43. PubMed ID: 3427833 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy. Gutsol AA; Blanco P; Hale TM; Thibodeau JF; Holterman CE; Nasrallah R; Correa JWN; Afanasiev SA; Touyz RM; Kennedy CRJ; Burger D; Hébert RL; Burns KD PLoS One; 2022; 17(2):e0264136. PubMed ID: 35176122 [TBL] [Abstract][Full Text] [Related]
17. Renal insufficiency in nephrosclerosis (benign nephrosclerosis resp. transition from benign to secondary malignant nephrosclerosis) correlations between morphological and functional parameters. Grund KE; Mackensen S; Grüner J; Neunhoeffer J; Bader H; Bohle A Klin Wochenschr; 1978 Dec; 56(23):1147-54. PubMed ID: 713435 [TBL] [Abstract][Full Text] [Related]